URMILA REGMI: Open Payments
NPI 1174266746 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$118 in 6 payments from 5 companies in 2025. Trend: 2023 $313 · 2024 $163 · 2025 $118
Food & beverage: $118
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $47 |
| Boston Scientific Corporation | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: OPSYNVI, ACCOLADE SR, ELIQUIS, JARDIANCE, GATTEX.
Industry payments across TX — which companies pay providers there.
